4//SEC Filing
Sathyanarayanan Sriram 4
Accession 0000899243-23-005694
CIK 0001659352other
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 4:31 PM ET
Size
14.5 KB
Accession
0000899243-23-005694
Insider Transaction Report
Form 4
Sathyanarayanan Sriram
Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2022-08-16+7,350→ 9,102 total - Sale
Common Stock
2022-08-17$2.21/sh−2,283$5,051→ 6,819 total - Exercise/Conversion
Common Stock
2023-02-16+7,350→ 14,169 total - Sale
Common Stock
2023-02-17$0.59/sh−2,407$1,425→ 11,762 total - Exercise/Conversion
Restricted Stock Units
2022-08-16−7,350→ 22,050 total→ Common Stock (7,350 underlying) - Exercise/Conversion
Restricted Stock Units
2023-02-16−7,350→ 14,700 total→ Common Stock (7,350 underlying)
Footnotes (4)
- [F1]Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
- [F2]The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
- [F3]Each RSU represents a contingent right to receive one share of common stock.
- [F4]On February 16, 2022, the reporting person was granted 29,400 RSUs, vesting in four equal installments every six months beginning on the six months anniversary of the grant date.
Documents
Issuer
Codiak BioSciences, Inc.
CIK 0001659352
Entity typeother
Related Parties
1- filerCIK 0001867898
Filing Metadata
- Form type
- 4
- Filed
- Feb 20, 7:00 PM ET
- Accepted
- Feb 21, 4:31 PM ET
- Size
- 14.5 KB